
Dolby Laboratories (NYSE:DLB – Free Report) – Research analysts at Barrington Research issued their Q1 2027 earnings per share estimates for Dolby Laboratories in a report issued on Wednesday, November 19th. Barrington Research analyst P. Sholl anticipates that the electronics maker will post earnings per share of $0.70 for the quarter. Barrington Research has a “Outperform” rating and a $95.00 price target on the stock. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.94 per share. Barrington Research also issued estimates for Dolby Laboratories’ Q2 2027 earnings at $1.14 EPS, Q3 2027 earnings at $0.80 EPS, Q4 2027 earnings at $0.86 EPS and FY2027 earnings at $3.49 EPS.
Several other equities analysts also recently commented on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Thursday, November 13th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Tigress Financial boosted their price objective on Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a report on Friday, August 15th. Finally, Robert W. Baird started coverage on Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.00.
Dolby Laboratories Trading Down 1.2%
DLB opened at $66.69 on Monday. The stock’s fifty day simple moving average is $68.49 and its 200 day simple moving average is $72.28. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66. The stock has a market cap of $6.39 billion, a PE ratio of 24.43 and a beta of 0.97.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The company had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. During the same period last year, the firm posted $0.61 earnings per share. The business’s revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS.
Dolby Laboratories Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd will be issued a dividend of $0.36 per share. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, December 2nd. Dolby Laboratories’s payout ratio is 54.75%.
Insider Activity
In related news, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction on Friday, November 21st. The stock was sold at an average price of $65.55, for a total value of $196,650.00. Following the transaction, the senior vice president owned 67,435 shares in the company, valued at approximately $4,420,364.25. This trade represents a 4.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP John D. Couling sold 6,164 shares of the business’s stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $66.12, for a total value of $407,563.68. Following the completion of the transaction, the senior vice president directly owned 115,338 shares of the company’s stock, valued at approximately $7,626,148.56. This trade represents a 5.07% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 59,164 shares of company stock worth $4,117,464. Corporate insiders own 38.39% of the company’s stock.
Hedge Funds Weigh In On Dolby Laboratories
Hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Dolby Laboratories by 2.7% during the 3rd quarter. Vanguard Group Inc. now owns 7,756,924 shares of the electronics maker’s stock worth $561,369,000 after acquiring an additional 203,411 shares in the last quarter. State Street Corp increased its stake in shares of Dolby Laboratories by 8.7% in the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after purchasing an additional 180,072 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Dolby Laboratories by 51.8% during the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Dolby Laboratories by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 1,556,571 shares of the electronics maker’s stock worth $116,159,000 after buying an additional 30,057 shares during the last quarter. Finally, First Trust Advisors LP boosted its stake in Dolby Laboratories by 22.7% in the third quarter. First Trust Advisors LP now owns 1,518,657 shares of the electronics maker’s stock valued at $109,905,000 after buying an additional 281,214 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Further Reading
- Five stocks we like better than Dolby Laboratories
- About the Markup Calculator
- D-Wave: Time to Buy the Dip? Or is the Fall Just Starting?
- Breakout Stocks: What They Are and How to Identify Them
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- Where to Find Earnings Call Transcripts
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
